- IBM (IBM.US): Signs a multi-year $240 million agreement with Together AI to deploy NVIDIA HGX B300 clusters on IBM Cloud.
- CME Group: 24-hour around-the-clock trading for silver will launch on September 11.
- CME Group will expand round-the-clock trading to include 100-ounce silver futures.
- AXSOME THERAPEUTICS, INC. : MORGAN STANLEY RAISES TARGET PRICE TO $251 FROM $242
- Immunic posts investor presentation highlighting vidofludimus calcium Phase 3 MS program
- Ton Strategy Q2 revenue surges on higher Gram staking rewards
- Fair Isaac’s FICO Marketplace adds Alogram fraud intelligence offerings
- KHD Humboldt Wedag Vermögensverwaltungs to release half-year financial report
- Oxy releases transcript of Q2 2026 earnings call
- Aveng forecasts FY loss narrows to A$17.6 million-A$14.4 million
- Intellistake provides scientific update on proposed NanoAi acquisition
- US Stock Market Preview | All Three Major Index Futures Rise, Nvidia (NVDA.US) Teams Up with Wall Street to Leverage $500 Billion, Yen Approaches 160 Again
- First Canadian Graphite signs collaboration agreement with Groupe Nipi, BBA for Lac Guéret Sud environmental study
- Butterfly Network director Erica Schwartz steps down after CDC director confirmation
- Getty Copper drills 194 m of 0.62% copper from 27 m at Getty North project
- Egypt's Ministry of Energy: Egypt will launch the Meleiha gas plant next month.
- Senstar Technologies to report Q2 2026 results, host conference call
- Tenet Fintech clarifies investor awareness contract with Perez totals USD 5,000, runs Aug. 1-Sept. 30
- Axil Brands updates financial calendar with fiscal Q4, full-year earnings release and investor call
- Collective Mining begins trading on Nasdaq after NYSE American delisting
- Protara net loss widens to $21.7 million in Q2 FY26; R&D expenses rise to $17 million
- Equinix backs Abbott’s standards for responsible Texas data center growth
- CME Group to Launch 24-Hour Silver Trading on September 11
- Nocera, INERGX form 50/50 energy joint venture targeting INERGX valuation of $250 million
- ManpowerGroup names Paychex CEO John B. Gibson Jr. to board
- 374Water signs MOU with Arcadis to pursue federal PFAS destruction projects
- 1606 Corp taps MDM Group to market planned Lufkin 55 MW powered-site acquisition to AI data center buyers
- LivePerson urges shareholders to back SoundHound merger ahead of Aug. 20 vote
- IBM, Together AI sign $240 million multi-year deal to scale open-source AI inference on IBM Cloud
- TASKUS, INC. <TASK.O>: MORGAN STANLEY RAISES TARGET PRICE TO $7.00 FROM $6.00
- HIMS & HERS HEALTH INC <HIMS.N>: MORGAN STANLEY RAISES TARGET PRICE TO $28.00 FROM $21.00
- Kalaris net loss widens to $11.52 million in Q2 FY26
- DEFINITIVE HEALTHCARE <DH.O>: MORGAN STANLEY CUTS TARGET PRICE TO $1.50 FROM $2.50
- GOPRO INC <GPRO.O>: MORGAN STANLEY CUTS TARGET PRICE TO $0.50 FROM $1.30
- BRIDGEBIO PHARMA INC <BBIO.O>: MORGAN STANLEY CUTS TARGET PRICE TO $97.00 FROM $98.00
- Imunon Q2 FY26 net loss widens to $2.8 million
- TON Strategy Q2 FY26 net income from continuing operations swings to USD 83.53 million; revenue more than doubled to USD 15 million
- A2Z Cust2Mate wins follow-on order for 4,000 smart carts from Sapir Group
- Joby Aviation agrees to buy defense tech firm Resonant Sciences
- UK MHRA expands Rhythm’s IMCIVREE authorization to treat acquired hypothalamic obesity
- Lelantos unit Airtopia signs construction management deal with Suntex’s JA Development
- CME Group expands 24/7 trading to 100-ounce silver futures from Sept. 11
- TRX staking declines as TRON’s Q2 USDT transfers hit $2.1T: Can demand beat supply?
- Nova management to attend Citi Global Technology Conference fireside chat
- TurnOnGreen unit Digital Power shifts DUC800-28 military-grade power supply to full-scale production
- Fort Technology signs deal to buy 50.1% of Logia USA for US$125,000 in shares
- IDEX Metals flags four chargeability targets at Freeze copper project in Idaho after 91-line-kilometer IP survey
- LB Pharmaceuticals Q2 FY26 net loss widens to $51.6 million
- Joby Aviation to acquire defense tech firm Resonant Sciences for about $500 million
- Mereo BioPharma signs option-and-license deal with Sentynl for US rights to alvelestat in AATD lung disease
- Tanger begins renovation of 500,000-sq-ft Tanger Outlets Foley, adds 20,000-sq-ft dining zone
- Formula One owner Liberty Media prices USD 600 million convertible senior notes offering
- RingCentral management to speak at Oppenheimer Technology, Internet & Communications Conference
- CN posts record Western Canada grain haul of 33.8 million metric tonnes in 2025-26 crop year
- Diodes joins Needham Semiconductor & SemiCap 1x1 conference
- Abundia Global Impact posts Q2 revenue of $2 million after RPD integration
- Perpetuals.com CSO Nicoletti to present at Investor Summit webcast
- Reuters survey: The yield on the US two-year Treasury note is expected to drop to 4.07% within three months, 3.92% within six months, and 3.80% within one year (the July survey indicated 4.00%, 3.90%, and 3.85% respectively).
- Reuters survey: 18 out of 22 bond strategists say that over the next three months, the yield on the US 10-year Treasury bond is more likely to exceed expectations than fall below them.
- BRIEF-Imunon Q2 EPS USD -0.54
- Reuters survey: The yield on 10-year US Treasury bonds is expected to fall to 4.50% in three months and remain at that level for the following three months, dropping to 4.34% after one year (July survey figures were 4.48%, 4.48%, and 4.39%, respectively).
- BRIEF-Protara Therapeutics Q2 EPS USD -0.36
- BRIEF-Theriva Biologics Q2 Net Income USD -3.217 Million
- BRIEF-Kalaris Therapeutics Inc Q2 Operating Income USD -12.386 Million Vs. IBES Estimate USD -12.5 Million
- Coya net loss widens to $6.64 million in Q2 FY26; R&D expense rises to $5.03 million
- KHD Humboldt Wedag schedules half-year financial report release
- LB Pharmaceuticals 2Q Research and Development Expenses $44.1M >LBRX
- Coya Therapeutics 2Q Rev $243,745 >COYA
- Analyst Who Called $3.37 XRP Top States What to Expect If XRP Breaks $1.01
- Big Sky Industrial 2Q Rev $2.13M >BSIN
- LB Pharmaceuticals 2Q Loss/Shr $1.71 >LBRX
- Big Sky Industrial 2Q Loss/Shr 4c >BSIN
- Big Sky Industrial 2Q Loss $2.34M >BSIN
- Fort Technology Signs Agreements For The Acquisition Of Logia USA - Fuel Integrity Solutions For Data Centers Company >FORT.V
- Samudera Shipping unit BOS orders new 696-TEU container vessel for 2028 delivery
- Bitcoin decouples from software stocks, signaling investor shifts
- RIOT PLATFORMS, INC. <RIOT.O>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO $36 FROM $28
- Foreign Media: After XRP Accounts Surpass 8 Million, the Top 1% Threshold Drops to 44,771 Tokens
- web3: XLM falls below key support, derivatives data weakens
- Syra Health Q2 FY26 swings to profit of $250,242; revenue rises 23% to $2.4 million
- US Dollar: CPI keeps USD in tight ranges – OCBC
- Token Unlocks This Week: Why Supply Share Matters More Than Value
- CALFRAC WELL SERVICES LTD <CFW.TO>: ATB CORMARK CAPITAL MARKETS RAISES TO OUTPERFORM FROM SECTOR PERFORM; RAISES TARGET PRICE TO C$9 FROM C$7.5
- Web3: Bitcoin falls below $64,000, ETFs turn to net outflows
- GBP/USD Price Forecast: Holds Descending Triangle breakout
- Zura Bio posts corporate overview highlighting tibulizumab dual IL-17/BAFF bispecific program in Phase 2 development
- Qatar says Oman-Iran talks reach advanced stage
- A storage tank at Libya's main oil refinery was hit and caught fire.
- BRIEF-Neuronetics Q2 Operating Expenses USD 22.7 Million
- Neuronetics Q2 net loss narrows to $3.4 million; revenue rises 9.1% to $41.6 million vs Q2 2025
- Neuronetics 2Q Loss $3.44M >STIM
- Zenergy signs cooperation MoU with RSG Stockholm for modular housing projects pipeline of 360 apartments
- SpectraCure chair Wennberg lifts stake to 2.66% voting rights after rights issue
- iShares Trust trims Adtran voting rights to 4.2% from 4.23%
- ClearSign appoints ex-ExxonMobil technology leader Larry Saddler to board
- Lasernet Group to delist from Nasdaq Stockholm; last trading day Aug. 24, 2026
- Signet names Jamie Cygielman president of Zales, Banter
- Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
- Xtant Medical Holdings Cuts 2026 View To Rev $99M-$103M >XTNT
- Hemab Therapeutics 2Q Research and Development Expenses $20.3M >COAG
